Skip to main content

Capital World Investors

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1422849 LOS ANGELES, CA

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,096,376,160
+$17,299,585 QoQ
Shares Held
1,419,000
+1.5% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.99816772374912.ToString("F0")% Shared 0.ToString("F0")% None 0.001832276250880902.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capital World Investors holds $23,534,298,325 across 32 Biotechnology names. REGN ranks #5 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,419,000 $1,096,376,160

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,096,376,160 1,419,000
2025-12-31 $1,079,076,575 1,398,003
2025-09-30 $1,123,621,250 1,998,366
2025-06-30 $1,032,159,450 1,966,018
2025-03-31 $1,229,539,841 1,938,634
2024-12-31 $1,979,550,823 2,778,980
2024-09-30 $4,518,636,349 4,298,387
2024-06-30 $4,875,378,177 4,638,667
2024-03-31 $4,480,251,388 4,654,855
2023-12-31 $4,506,053,670 5,130,485
2023-09-30 $4,203,135,703 5,107,339
2023-06-30 $3,988,171,482 5,550,382
2023-03-31 $4,790,817,598 5,830,586
2022-12-31 $4,503,854,428 6,242,435
2022-09-30 $4,288,628,383 6,225,599
2022-06-30 $3,685,465,600 6,234,611
2022-03-31 $4,155,483,062 5,949,834
2021-12-31 $3,361,981,975 5,323,635
2021-09-30 $3,219,557,600 5,320,000
2021-06-30 $2,964,706,302 5,307,957
2021-03-31 $2,925,954,536 6,184,120
2020-12-31 $3,355,569,978 6,945,768
2020-09-30 $3,719,385,438 6,644,370
2020-06-30 $4,325,234,145 6,935,355
2020-03-31 $3,483,109,291 7,133,280